Sai Sannidhi Pharmaceutical (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 2.49%
- Net Worth -10.50%
- Total Assets -6.70%
About Sai Sannidhi Pharmaceutical (India)
Sai Sannidhi Pharmaceutical (India) Private Limited (SSPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 November 2015 (Nine years and three months 22 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Munagala and Deepthi Somisetty serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2015PTC101485
- Company No.
101485
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sai Sannidhi Pharmaceutical (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepthi Somisetty  | Managing Director | 03-Nov-2015 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajendra Munagala | Additional Director | 07-Feb-2022 | Current |
Financial Performance of Sai Sannidhi Pharmaceutical (India).
Sai Sannidhi Pharmaceutical (India) Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 2.49% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sai Sannidhi Pharmaceutical (India)?
Unlock access to Sai Sannidhi Pharmaceutical (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sri Sai Dwarakamai Infra LlpRajendra Munagala and Deepthi Somisetty are mutual person
- Sai Dwarakamai Pharma Llp
Rajendra Munagala and Deepthi Somisetty are mutual person
- Srilakshya Credit And Investment Rating Agency Limited
Rajendra Munagala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sai Sannidhi Pharmaceutical (India)?
Unlock and access historical data on people associated with Sai Sannidhi Pharmaceutical (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Sannidhi Pharmaceutical (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Sannidhi Pharmaceutical (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
